These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 19350387)
1. Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer. Han W; Kang SY; Breast Cancer Res Treat; 2010 Jan; 119(1):193-200. PubMed ID: 19350387 [TBL] [Abstract][Full Text] [Related]
2. Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society. Ahn SH; Son BH; Kim SW; Kim SI; Jeong J; Ko SS; Han W; J Clin Oncol; 2007 Jun; 25(17):2360-8. PubMed ID: 17515570 [TBL] [Abstract][Full Text] [Related]
3. Do very young Korean breast cancer patients have worse outcomes? Kim JK; Kwak BS; Lee JS; Hong SJ; Kim HJ; Son BH; Ahn SH Ann Surg Oncol; 2007 Dec; 14(12):3385-91. PubMed ID: 17899295 [TBL] [Abstract][Full Text] [Related]
4. Male breast cancer in the veterans affairs population: a comparative analysis. Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768 [TBL] [Abstract][Full Text] [Related]
5. Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Son BH; Kwak BS; Kim JK; Kim HJ; Hong SJ; Lee JS; Hwang UK; Yoon HS; Ahn SH Arch Surg; 2006 Feb; 141(2):155-60. PubMed ID: 16490892 [TBL] [Abstract][Full Text] [Related]
6. Breast cancer outcome and predictors of outcome: are there age differentials? Albain KS; Allred DC; Clark GM J Natl Cancer Inst Monogr; 1994; (16):35-42. PubMed ID: 7999467 [TBL] [Abstract][Full Text] [Related]
7. An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience. Haas JA; Schultz DJ; Peterson ME; Solin LJ Cancer J Sci Am; 1998; 4(5):308-15. PubMed ID: 9815295 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
9. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
10. Ethnic differences in breast cancer in Hawai'i: age, stage, hormone receptor status, and survival. Braun KL; Fong M; Gotay CC; Chong CD Pac Health Dialog; 2004 Sep; 11(2):146-53. PubMed ID: 16281692 [TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of resectable breast cancer: a report of 6 263 cases]. Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535 [TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA; Borofsky ND; Massardo S; Orentreich N Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [TBL] [Abstract][Full Text] [Related]
13. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women. Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882 [TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519 [TBL] [Abstract][Full Text] [Related]
15. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Figueiredo JC; Ennis M; Knight JA; McLaughlin JR; Hood N; O'Malley F; Andrulis IL; Goodwin PJ Breast Cancer Res Treat; 2007 Sep; 105(1):69-80. PubMed ID: 17115108 [TBL] [Abstract][Full Text] [Related]
16. Prognosis of premenopausal breast cancer and childbirth prior to diagnosis. Phillips KA; Milne RL; Friedlander ML; Jenkins MA; McCredie MR; Giles GG; Hopper JL J Clin Oncol; 2004 Feb; 22(4):699-705. PubMed ID: 14966094 [TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205 [TBL] [Abstract][Full Text] [Related]
18. Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. Swanson GM; Lin CS J Natl Cancer Inst Monogr; 1994; (16):69-77. PubMed ID: 7999472 [TBL] [Abstract][Full Text] [Related]
19. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial. Alkner S; Bendahl PO; Fernö M; Nordenskjöld B; Rydén L; Eur J Cancer; 2009 Sep; 45(14):2496-502. PubMed ID: 19535242 [TBL] [Abstract][Full Text] [Related]
20. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Loi S; Milne RL; Friedlander ML; McCredie MR; Giles GG; Hopper JL; Phillips KA Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1686-91. PubMed ID: 16030102 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]